The Food and Drug Administration (FDA) has introduced new guidelines for COVID-19 vaccines, focusing on those at highest risk for severe complications. The updated strategy will maintain the ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

The Trump administration released a more stringent set of guidelines for approving Covid-19 ... approval, FDA Commissioner Dr. Marty Makary and the agency’s new vaccines chief, Dr. Vinay Prasad ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Critics fear that U.S. Department of Health and Human Services chief RFK, Jr., known for his antivaccine views, has picked a ...

U.S. health officials, following recommendations by infectious disease experts, have been urging annual COVID-19 boosters for ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for ...